Placing a Report of Bicalutamide-Induced Hepatotoxicity in the Context of Current Standards of Care for Transgender Adolescents
J Adolesc Health
.
2024 Jan;74(1):5-6.
doi: 10.1016/j.jadohealth.2023.10.010.
Authors
Daniel Shumer
1
,
Stephanie A Roberts
2
Affiliations
1
Division of Pediatric Endocrinology, C.S. Mott Children's Hospital/University of Michigan Medical School, Ann Arbor, Michigan.
2
Division of Endocrinology, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts.
PMID:
38103922
DOI:
10.1016/j.jadohealth.2023.10.010
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Adolescent
Chemical and Drug Induced Liver Injury* / etiology
Humans
Standard of Care
Transgender Persons*
Transsexualism*
Substances
bicalutamide
Grants and funding
K08 HD100595/HD/NICHD NIH HHS/United States